Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-12-08
DOI
10.3389/fphar.2021.740707
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adverse drug reaction risks obtained from meta-analyses and pharmacovigilance disproportionality analyses are correlated in most cases
- (2021) Charles Khouri et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns
- (2021) Anthony Touafchia et al. CLINICAL MICROBIOLOGY AND INFECTION
- Leveraging the Variability of Pharmacovigilance Disproportionality Analyses to Improve Signal Detection Performances
- (2021) Charles Khouri et al. Frontiers in Pharmacology
- Investigating Overlap in Signals from EVDAS, FAERS, and VigiBase®
- (2020) Ulrich Vogel et al. DRUG SAFETY
- Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations
- (2020) Ola Caster et al. DRUG SAFETY
- COVID‐19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose‐6‐phosphate dehydrogenase deficiency
- (2020) Yan Beauverd et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Characterizing the adverse dermatologic effects of hydroxychloroquine: A systematic review
- (2020) Ajay N. Sharma et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cerebral Venous Thrombosis Associated with COVID-19
- (2020) D.D. Cavalcanti et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Serious adverse events with tocilizumab: Pharmacovigilance as an aid to prioritize monitoring in COVID‐19
- (2020) Milo Gatti et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Hepatic disorders with the use of remdesivir for coronavirus 2019 (COVID-19)
- (2020) François Montastruc et al. Clinical Gastroenterology and Hepatology
- Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance
- (2020) Emanuel Raschi et al. Targeted Oncology
- Hydroxychloroquine-Associated Hypoglycemia in Hemodialysis Patients With COVID-19
- (2020) Ahmet Burak Dirim et al. Kidney International Reports
- Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre‐COVID‐19 reports
- (2020) Adam Goldman et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports
- (2020) Alem Zekarias et al. DRUG SAFETY
- Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study
- (2020) Philippe Garcia et al. DRUG SAFETY
- Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance
- (2020) Emanuel Raschi et al. DRUG SAFETY
- Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study
- (2020) Jennifer C E Lane et al. RHEUMATOLOGY
- Rapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications
- (2020) Jaykaran Charan et al. Expert Review of Clinical Pharmacology
- Bradycardia during hypoxaemic airway crises. Does atropine treat the patient or the anaesthetist?
- (2019) A. Higgs et al. ANAESTHESIA
- Staphylococcus aureus , master manipulator of the human hemostatic system
- (2018) L. Liesenborghs et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Large-scale mining disease comorbidity relationships from post-market drug adverse events surveillance data
- (2018) Chunlei Zheng et al. BMC BIOINFORMATICS
- The IMI PROTECT project: purpose, organizational structure, and procedures
- (2016) Robert F. Reynolds et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- A Method for the Minimization of Competition Bias in Signal Detection from Spontaneous Reporting Databases
- (2015) Mickael Arnaud et al. DRUG SAFETY
- Comparison of Statistical Signal Detection Methods Within and Across Spontaneous Reporting Databases
- (2015) Gianmario Candore et al. DRUG SAFETY
- Identification of Suicide-Related Events Through Network Analysis of Adverse Event Reports
- (2014) Alwis Nazir et al. DRUG SAFETY
- A new method for constructing networks from binary data
- (2014) Claudia D. van Borkulo et al. Scientific Reports
- Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference
- (2012) Feixiong Cheng et al. PLoS Computational Biology
- The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature
- (2011) M. Jallouli et al. JOURNAL OF NEUROLOGY
- The Small World of Psychopathology
- (2011) Denny Borsboom et al. PLoS One
- Network medicine: a network-based approach to human disease
- (2010) Albert-László Barabási et al. NATURE REVIEWS GENETICS
- An empirical framework for binary interactome mapping
- (2008) Kavitha Venkatesan et al. NATURE METHODS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now